Kåre Schultz

Overview

Kåre Schultz received an average of $25M in total compensation, including $1M in salary, at Teva Pharmaceutical Industries between 2017 and 2018.

Source: SEC filings on April 16, 2019 and April 25, 2018.

Related executives

We found nine more executives who work or worked at Teva Pharmaceutical Industries.

Carlo de Notaristefani

Teva Pharmaceutical Industries

Executive Vice President, Global Operations

Hafrun Fridriksdottir

Teva Pharmaceutical Industries

Executive Vice President, Global Research and Development

Mark Sabag

Teva Pharmaceutical Industries

Executive Vice President, Global Human Resources

Michael McClellan

Teva Pharmaceutical Industries

Chief Financial Officer

Yitzhak Peterburg

Teva Pharmaceutical Industries

Chief Executive Officer

Rob Koremans

Teva Pharmaceutical Industries

Chief Executive Officer

Michael Hayden

Teva Pharmaceutical Industries

Chief Scientific Officer

Eyal Desheh

Teva Pharmaceutical Industries

Chief Financial Officer

News

You may also like